Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.

Clinical trial NCT00317135 · COMPLETED

Trial details

NCT number: NCT00317135
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Hepatitis B Whole Cell Pertussis Haemophilus Influenzae Type b Tetanus

Start date: 2003-12-11
Primary completion: 2004-10-23
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.